Skip to content
Wednesday 2 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,735.45
-0.50%
DAX
25,770.97
-0.77%
CAC 40
8,252.17
-0.60%
STOXX 50
6,341.01
-0.44%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 01 March 2021 6:51 pm

Demand for workspace rapid Covid tests jumps as offices prepare to reopen

By: Tom Saunders

Add as a preferred source on Google
Bournemouth Symphony Orchestra Rehearse To Stream Live Performances Through Lockdown
The UK medicines regulator (MHRA) has extended the emergency use approval of Innova's rapid Covid test, despite the US FDA issuing a severe warning about them last week.

Diagnostics company Excalibur Healthcare, which provide fast-acting lateral flow tests, said demand had increased for its test and it had seen a surge in calls from companies wanting to implement workplace testing regimes.

Excalibur sold hundreds of thousands of lateral flow tests in the seven days after Boris Johnson announced his roadmap out of lockdown.

Excalibur’s chief executive and founder Sir Chris Evans said: “We have new firms contacting us and are adding new customers every single week or day. Everybody now realises they will need to test. They are desperate and as soon as they can open up, they will.”

Lateral flows tests have come a long way since they were first introduced, the company said.

Excalibur’s test was found to be 96 per cent accurate, according to a study at the Catholic University of Korea Incheon St Mary’s Hospital.

Innova also released a lateral flow test that 76 per cent accurate, according to a pilot study conducted in Liverpool.

Crucially, both tests are better at detecting the virus when there is a high viral load, meaning the more infectious you are the more likely you are to receive an accurate test.

Read more

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • Jaguar reveals the Type 01’s screen-free interior

  • Easyjet’s over-60s recruitment push is economically necessary

  • FCA ‘worked backwards’ to justify motor finance redress, say lenders

More from Morning Wire

  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Brits fear AI is slipping out of human control after ‘rogue’ systems escape tests

    Tech
    Dario Amodei, CEO of Anthropic, speaking at a tech conference podium, wearing a suit and addressing the audience.
  • Why Liverpool deal proves demand for Premier League stakes is soaring

    Sport Business
    Liverpool FC fans cheering in a stadium, holding up red scarves and wearing team jerseys.
  • Rehlko Expands Power Plus™ Connected-Services Capabilities, Enhancing Value Across Installed Base

    Business Wire
  • KBRA Releases Research – The End of the RRF: Trade Adjustment and Financing Challenge

    Business Wire
  • Manufacturers overcome gloomy economy as output surge continues

    Industrials
    Manufacturing sector faces mounting tribunal pressures amid economic uncertainty
  • Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

    Business Wire
  • This Is the Moment Everything Changed: Ascensia Launches Global Art and Photography Competition for World Diabetes Day

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook